Growth funding Baird Capital actively deploys venture, growth equity and private equity investments across global sectors and has recent activity in growth capital, indicating ongoing capital deployment opportunities with portfolio companies and potential co‑investors.

Healthcare and services Recent investments include Newmarket Strategy in pharmaceutical services and healthcare advisory, signaling a focus area where BD efforts can align with related services, compliance, and operational optimization opportunities for portfolio companies.

Strategic exits The firm engages in exits such as selling Subsea Technology & Rentals stakes, suggesting an appetite for portfolio optimization through strategic divestitures — potential introductions to buyers, SPACs, or strategic partners seeking similar assets.

Global network With 60 investment and operating professionals across the US, UK, and Asia, there are built‑in channels for deal flow, co‑investments, and cross‑border collaborations to scale outreach and accelerate introductions to relevant management teams.

Tech enabled Baird Capital utilizes a modern tech stack (Azure, Dynamics, Office 365, Smartsheet, Sprout Social) which indicates readiness for data‑driven deal sourcing, portfolio management, and marketing automation opportunities to engage decision makers efficiently.